By Stewart Eisenhart, Emergo Group
Although premarket registration and quality management system compliance garner a lot of attention from medical device companies eager to establish themselves in their target markets, successful commercialization also requires viable post-market surveillance (PMS) efforts.
Get the full story here at the Emergo Group’s blog.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.